These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 24744135)

  • 41. ¹⁸F-fluoro-deoxy-glucose focal uptake in very small pulmonary nodules: fact or artifact? Case reports.
    Calcagni ML; Taralli S; Maggi F; Rufini V; Treglia G; Leccisotti L; Bonomo L; Giordano A
    World J Surg Oncol; 2012 Apr; 10():71. PubMed ID: 22540935
    [TBL] [Abstract][Full Text] [Related]  

  • 42. 18F-Fluorodeoxyglucose Positron Emission Tomography/Magnetic Resonance in Lymphoma: Comparison With 18F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography and With the Addition of Magnetic Resonance Diffusion-Weighted Imaging.
    Giraudo C; Raderer M; Karanikas G; Weber M; Kiesewetter B; Dolak W; Simonitsch-Klupp I; Mayerhoefer ME
    Invest Radiol; 2016 Mar; 51(3):163-9. PubMed ID: 26784400
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Role of
    Dolci C; Ceppi L; Guerra L; Crivellaro C; Lamanna M; Adorni M; Elisei F; Bonazzi CM; Sina F; Fruscio R; Messa C
    Int J Gynecol Cancer; 2019 Oct; 29(8):1298-1303. PubMed ID: 31366569
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Diagnostic performance of fluorodeoxyglucose positron emission tomography/magnetic resonance imaging fusion images of gynecological malignant tumors: comparison with positron emission tomography/computed tomography.
    Nakajo K; Tatsumi M; Inoue A; Isohashi K; Higuchi I; Kato H; Imaizumi M; Enomoto T; Shimosegawa E; Kimura T; Hatazawa J
    Jpn J Radiol; 2010 Feb; 28(2):95-100. PubMed ID: 20182843
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Ophthalmologic abnormalities on FDG-PET/CT: a pictorial essay.
    Muzaffar R; Shousha MA; Sarajlic L; Osman MM
    Cancer Imaging; 2013 Mar; 13(1):100-12. PubMed ID: 23524026
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Lymph node metastasis diagnosis using positron emission tomography with 2-[18F] fluoro-2-deoxy-D-glucose as a tracer and computed tomography in surgical cases of non-small cell lung cancer.
    Ose N; Sawabata N; Minami M; Inoue M; Shintani Y; Kadota Y; Okumura M
    Eur J Cardiothorac Surg; 2012 Jul; 42(1):89-92. PubMed ID: 22290887
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [¹⁸F]fluorodeoxyglucose PET/computed tomography in breast cancer and gynecologic cancers: a literature review.
    Hildebrandt MG; Kodahl AR; Teilmann-Jørgensen D; Mogensen O; Jensen PT
    PET Clin; 2015 Jan; 10(1):89-104. PubMed ID: 25455882
    [TBL] [Abstract][Full Text] [Related]  

  • 48. PET/MR Imaging in Gynecologic Oncology.
    Ohliger MA; Hope TA; Chapman JS; Chen LM; Behr SC; Poder L
    Magn Reson Imaging Clin N Am; 2017 Aug; 25(3):667-684. PubMed ID: 28668166
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Use of FDG PET/CT in Patients with Pancoast Tumors: Does It Add Any Contribution to Patient Management?
    Ozmen O; Yilmaz U; Dadali Y; Tatci E; Gokcek A; Aydin E; Okuyucu K; Arslan N
    Cancer Biother Radiopharm; 2015 Oct; 30(8):359-67. PubMed ID: 26367245
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Positron emission tomography application for gynecologic tumors.
    Nakamoto Y; Saga T; Fujii S
    Int J Gynecol Cancer; 2005; 15(5):701-9. PubMed ID: 16174216
    [TBL] [Abstract][Full Text] [Related]  

  • 51. A prospective evaluation of the utility of 2-deoxy-2-[(18) F]fluoro-D-glucose positron emission tomography and computed tomography in staging locally advanced gastric cancer.
    Smyth E; Schöder H; Strong VE; Capanu M; Kelsen DP; Coit DG; Shah MA
    Cancer; 2012 Nov; 118(22):5481-8. PubMed ID: 22549558
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Extrarenal malignant rhabdoid tumor in childhood application of 18F-FDG PET/CT.
    Howman-Giles R; McCowage G; Kellie S; Graf N
    J Pediatr Hematol Oncol; 2012 Jan; 34(1):17-21. PubMed ID: 22052165
    [TBL] [Abstract][Full Text] [Related]  

  • 53. PET/CT in gynecologic cancer: present applications and future prospects--a clinician's perspective.
    Amit A; Schink J; Reiss A; Lowenstein L
    Obstet Gynecol Clin North Am; 2011 Mar; 38(1):1-21, vii. PubMed ID: 21419325
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Positron emission tomography/computerized tomography functional imaging of esophageal and colorectal cancer.
    Larson SM; Schoder H; Yeung H
    Cancer J; 2004; 10(4):243-50. PubMed ID: 15383205
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Evaluation of thymic tumors with 18F-FDG PET-CT: a pictorial review.
    Sharma P; Singhal A; Kumar A; Bal C; Malhotra A; Kumar R
    Acta Radiol; 2013 Feb; 54(1):14-21. PubMed ID: 23377872
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Bone marrow 18F-fluoro-2-deoxy-D-glucose positron emission tomography/computed tomography cannot replace bone marrow biopsy in diffuse large B-cell lymphoma.
    Adams HJ; Kwee TC; Fijnheer R; Dubois SV; Nievelstein RA; de Klerk JM
    Am J Hematol; 2014 Jul; 89(7):726-31. PubMed ID: 24711255
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Ferret thoracic anatomy by 2-deoxy-2-(18F)fluoro-D-glucose (18F-FDG) positron emission tomography/computed tomography (18F-FDG PET/CT) imaging.
    Wu A; Zheng H; Kraenzle J; Biller A; Vanover CD; Proctor M; Sherwood L; Steffen M; Ng C; Mollura DJ; Jonsson CB
    ILAR J; 2012; 53(1):E9-21. PubMed ID: 23382267
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Current evidence base of FDG-PET/CT imaging in the clinical management of malignant pleural mesothelioma: emerging significance of image segmentation and global disease assessment.
    Basu S; Saboury B; Torigian DA; Alavi A
    Mol Imaging Biol; 2011 Oct; 13(5):801-11. PubMed ID: 21136185
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Imaging in endocrinology: 2-[18F]-fluoro-2-deoxy-D-glucose positron emission tomography/computed tomography in differentiated thyroid carcinoma: clinical indications and controversies in diagnosis and follow-up.
    Salvatori M; Biondi B; Rufini V
    Eur J Endocrinol; 2015 Sep; 173(3):R115-30. PubMed ID: 25947140
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Impact of (18) F-fluorodeoxyglucose (FDG)-positron-emission tomography/computed tomography (PET/CT) on management of patients with carcinoma invading bladder muscle.
    Mertens LS; Fioole-Bruining A; Vegt E; Vogel WV; van Rhijn BW; Horenblas S
    BJU Int; 2013 Oct; 112(6):729-34. PubMed ID: 23790129
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.